Ipca Laboratories (BOM:524494) ROCE % : 14.82% (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ipca Laboratories's annualized ROCE % for the quarter that ended in Dec. 2023 was 14.82%.

Ipca Laboratories ROCE % Historical Data

The historical data trend for Ipca Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories ROCE % Chart

Ipca Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

17.21

20.44

31.62

20.66

12.18

Ipca Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															11.06	8.65	16.61	12.39	14.82

Ipca Laboratories ROCE % Calculation

Ipca Laboratories's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	7903.8	/	( ( (76235.3 - 14658.8)	+	(86264.3 - 18058.2) )	/ 2 )
	=	7903.8	/	( (61576.5	+	68206.1)	/ 2 )
	=	7903.8	/	64891.3
	=	12.18 %

Ipca Laboratories's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	12891.6	/	( ( (113838 - 26863)	+	(0 - 0) )	/ 1 )
	=	12891.6	/	( ( 86975	+	0 )	/ 1 )
	=	12891.6	/	86975
	=	14.82 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Ipca Laboratories (BOM:524494) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ipca Laboratories ROCE % Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipca Laboratories (BOM:524494) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » ROCE %

Traded in Other Exchanges

IPCALAB:India

Address

125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067

Website

https://www.ipca.com

Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (BOM:524494) Headlines

No Headlines